Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06662942 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

StrataMGT in the Reduction of Vulvar Lichen Sclerosus (LS) Symptoms

Study acronym: LS
StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 8, 2024 (before its estimated October 16, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Re-verified, no change to tracked fieldsv2
  2. Study First Submitted
This study is designed to evaluate the efficacy and safety of StrataMGT for the management of vulvar lichen sclerosus symptoms.
Trial Details
NCT Number NCT06662942
Lead Sponsor Andrew T. Goldstein, MD
Collaborators: Stratpharma AG
Conditions
(from sponsor)		 Vulvar Lichen Sclerosus
Related terms Vulvar Lichen Sclerosus
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov